Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – June 2022

SATISFACTORY RESULTS IN A CONTINUED CHALLENGING MARKETapril–june 2022 · Sales volume amounted to 5,371 (6,100 tonnes) a decline by 12%. · Net sales amounted to SEK 267.1 (246.3) million, an increase by 8%. The organic increase was 5%. · Operating profit amounted to SEK 13.5 (23.7) million, a decline by 43%. The adjusted operating profit amounted to SEK 13.5 (26.4) million, a decline by 49%. · The operating margin declined to 5.0% (9.6%) and adjusted operating margin declined to 5.0% (10.7%). · Profit for the period amounted to SEK 9.4 (18.6) million, a decline by 49%. ·

New patent approval in Hong Kong for Episurf Medical

The Intellectual Property Department (IPD) of Hong Kong has granted another patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Method and node for manufacturing a surgical kit for cartilage repair”, covers a medical image segmentation process for 3D visualisation of anatomical joints. “Image segmentation is a part of the technology around Episurf Medical’s individualised joint implants and surgical instruments. This patent adds on to previous patents within this area and broadens the protection for the company’s imaging technology in Hong Kong,”, says Katarina Flodström,

Nixu successfully pilots a Smart City digital service for the City of Jyväskylä together with IOXIO

Nixu Corporation, press release August 18, 2022 at 09:00 a.m. EESTNixu, together with IOXIO, has delivered a trusted data sharing pilot for the City of Jyväskylä. The pilot has been helping the City of Jyväskylä to establish an interoperable service infrastructure offered by a Smart City operator in the region. Nixu’s Identity and Access Management solution (IAM), together with IOXIO’s Dataspace service, has been successfully used in the first Smart City use case, which enables fully remote, easy, and secure control of access to both digital services as well as physical spaces. The

Interim report January – March 2022

Oslo, Norway, August 18, 2022 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the period January 1 – June 30, 2022. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Genetic Analysis CEO Ronny Hermansen comments:“As the first six months of 2022 have passed, I am proud to say that we keep on delivering on our objectives set out in the IPO. In the past quarter, we continued our preparation to expand globally to major markets and entered a strategic collaboration agreement

Publication of Orthex’s Half-Year Financial Report on 25 August 2022 and invitation to the result presentation on the same day

Orthex Corporation, Press release, 18 August 2022 at 9.00 a.m. EESTOrthex will publish its Half-Year Financial Report for the period January−June 2022 on Thursday, 25 August 2022 at around 09:00 a.m. EEST.Orthex’s CEO Alexander Rosenlew and CFO Saara Mäkelä will present the report on the same day at 11:00 a.m. EEST in a webcast. The webcast can be joined through this link 

Humana reports second quarter and half-year 2022 results

Acquisition growth and room to improve marginsSecond quarter, April–June 2022 · Operating revenue amounted to SEK 2,241 million (2,058), an increase of 8.9 percent, which was mainly due to acquisitions, previously opened units within Elderly Care and continued good growth in Norway. · Organic growth was 2.2 percent (4.2). Organic growth was driven by Elderly Care, Norway and Finland, while fewer assistance hours within Personal Assistance and closed units in Individual & Family inhibited growth.   · Operating profit amounted to SEK 65m (107), a decline of 39.4 percent. The

Fractal Gaming Group Interim Report January-June 2022

Second quarter 2022 · Net sales amounted to SEK 95.4 million (103.7). · Product profit amounted to SEK 29.3 million (33.8), with a product margin of 30.7% (32.6). · EBITDA amounted to SEK -3.0 million (2.0), corresponding to an EBITDA margin of -3.2% (1.9). · EBIT amounted to SEK -7.5 million (-1.3), corresponding to an EBIT margin of -7.9% (-1.2). · Operating cash flow amounted to SEK -7.7 million (0.9). · Interest-bearing net debt was SEK 127.4 million (94.5). · Earnings per share amounted to SEK -0.1 (0.0) Hannes Wallin, CEO and Founder of Fractal comments:“

NeoDynamics Interim Report Jan-June 2022

Focus shifting towards the US Second Quarter 2022 · Revenues amounted to SEK 164 (411) thousand, of which SEK 141 (383) thousand capitalized costs and SEK 10 (0) thousand net sales, i.e., sales of finished products. · Net loss amounted to SEK -18,294 (-18,263) thousand. · Loss per share amounted to SEK -0.17 (-0.30). · Cash and cash equivalents amounted to SEK 49,903 (24,710 at year-end) thousand.   First Half 2022 · Revenues amounted to SEK 311 (816) thousand, of which SEK 141 (762) thousand capitalized costs and SEK 103 (22) thousand net sales, i.e., sales of

TC TECH Sweden AB (publ) publishes its interim report

TC TECH has today published its interim report for the period April 1 to Juni 30, 2022.Net sales amounted to 34 (0) TSEK in the second quarter of 2022. In the same period, net profit/loss totalled -8 187 (-2 557) TSEK. Cash flow from operating activities was -4 259 (-1 716) TSEK in the period from April 1[st] to June 30[th] 2022. Net sales amounted to 5 829 (0) TSEK in the first half of 2022, while net profit/loss totalled -12 201 (-6 657) TSEK. Cash flow from operating activities was -10 361 (-5 519) TSEK in the period from January 1[st] to June 30[th] 2022. Developments in the

Interim report

January 1 – June 30, 2022The first quarter in figures · Net sales amounted to TSEK 3,726 (2,258), +65%. · The loss after tax amounted to TSEK 9,212 (11,151). · The loss per share amounted to SEK 0.13 (0.19). · The cash flow from current operations was negative in the amount of TSEK 9,643 (9,162). · The gross margin reached 70,6% (56.3%). · Electrode sales volume increased by 60% and reached 9,550 (5,968) units. Repeat sales of electrodes to existing customers increased by 58%. January - June in figures · Net sales amounted to TSEK 7,987 (4,821), +66%. · The

Interim report, January–June 2022

Strong growth and clarity around Ovzon 3January–June 2022 · Revenue increased to TSEK 177,815 (70,346). Revenue for the period include compensation for divested production stock of TSEK 3,367 (-) · Operating profit amounted to TSEK -26,318 (-61,568) · Profit after tax amounted to TSEK 4,483 (-49,792). The result includes currency conversions and financial transaction costs of TSEK 31,420 (11,948) · Earnings per share amounted to SEK 0.09 (-1.08) April–June 2022 · Revenue increased to TSEK 77,928 (33,216) · Operating profit amounted to TSEK -8,810 (-30,910) ·

Interim report January–June 2022

John Mattson is strengthening the company for the futureIn the second quarter, John Mattson’s income from property management per share increased 85% year-on-year. Adjusted for non-recurring items in 2021, income from property management per share increased 63%. Growth in net asset value (NAV) per share increased 29%. “Following a period of strong growth, we are refining the property portfolio and making the company even stronger for the future. Through the sale of three properties, we are creating the preconditions for more cost-effective property management and have made clear progress

Karnov Group reports second quarter results 2022

Strong growth and ready for European expansionFinancial highlights second quarter · Net sales increased by 12.9% to SEK 227 m (201), organic growth was 8.5% and acquired growth accounted for 2.3%. Currency effect was 2.1%. · EBITA amounted to SEK 54 m (70) with EBITA margin of 23.9% (35.0%). Items affecting comparability amounted to SEK 20 m (0). · Adjusted EBITA amounted to SEK 74 m (70) with adjusted EBITA margin of 32.6% (35.0%). · Net result amounted to SEK -1 m (20), impacted by items affecting comparability of SEK 20 m (0). · Earnings per share amounted to SEK -0.01 (

Elos Medtech Interim Report January 1 - June 30, 2022

April – June 2022 · Net sales for the second quarter amounted to SEK 233.1 (181.0) million, an increase of 28.8 percent compared to the same quarter last year. Net sales in local currencies increased by 19.7 percent. · Operating profit amounted to SEK 37.8 (26.5) million, corresponding to an operating margin of 16.2 (14.7) percent. · Profit after net financial items amounted to SEK 38.8 (22.8) million. Net financial items were positively affected by exchange rate differences of SEK 3.6 (-0.9) million and totaled SEK 1.1 (-3.7) million. · Profit after tax amounted to SEK 29.7 (

Prostatype Genomics presents Quarterly Report

Prostatype Genomics AB has today published its quarterly report for the second quarter comprising the period from 1 April 2022 to 30 June 2022. The report is available on the company website .Quarter 2 (1 April – 30 June 2022) summarized · Net sales amounted to 8 TSEK. · Net revenue amounted to 8 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -6 886 TSEK. · Cash flow from current operations in the quarter amounted -5 515 TSEK. · Total cash flow for the period amounted to -5 615

Dignitana AB Publishes Q2 2022 Interim Report

Strategic growth aligned with clear vision:Strong growth continues at 30 percent Financial highlights Q2 2022 · Net sales amounted to 18,3 MSEK (14,0), an increase of 30 percent over the same period in 2021. · Operating result amounted to 0.1 MSEK (-9,4). · Net result after financial items amounted to -0,2 MSEK (-9,7). · Earnings per share were 0,00 SEK (-0,15). · Cash Balance amounted to 7,3 MSEK (36,3). · Average Daily Treatment Revenue (ADTR)* was 201 TSEK (163), an increase of 23 percent over the same period in 2021. Significant events during the period ·

Shares issued in connection with the guarantee compensation registered

The Swedish Companies Registration Office has now registered an increase in the share capital through a targeted new issue, which the Company informed about via a press release on 15 July 2022. The share capital increases by SEK 18,710.6 and now amounts to SEK 1,293,441.200. The number of shares increases by 187,106 shares and now amounts to 12,934,412 shares. For more information, please contact: Pierre Grönberg, Chief Executive OfficerJS Security Technologies Group AB

Systemair's Interim Report for the first quarter will be presented on August 25

Press Release, 18 August 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q1 for the financial year 2022/23 will be published at 13:00 CET on August 25, 2022. A telephone conference will be held at 13:30 CET on August 25, 2022. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference: Call 010-884 8016 alternative international call +44 20 3936 2999 and enter code 539199 minutes before start. The presentation will be published on group .systemair.com 

UPM and Dongsung Chemical announce strategic partnership to develop renewable products using bio-based raw materials

(UPM, Helsinki, 18 August 2022 at 09:00 EEST) – UPM and Dongsung Chemical announce a development partnership that will accelerate the introduction of renewable, sustainable forest-sourced materials into the Asian market and reduce fossil resource consumption. Dongsung Chemical, headquartered in South Korea and UPM Biochemicals, headquartered in Germany have agreed to form a strategic partnership to develop renewable products using bio-based raw materials, initially for footwear materials. Dongsung Chemical has signed a Letter of Intent for this strategic partnership to develop a

Interim Report Second Quarter 2022

NASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2022 – 30.06.2022. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: We are back in business in Denmark. Q2 2022 marked a milestone that we have been working hard to realize since 2019. We imported and began sales of our new THC Oil products to patients in Denmark. For Stenocare this

Interim report Q2: Continued strong organic growth within all segments

April – June 2022 · Net sales increased with 86 % and amounted to SEK 911 (491) million. · Organic growth amounted to 25 (44) %. · Adjusted EBIT increased to SEK 75 (47) million with a margin of 8.2 (9.5) %. · Profit for the period amounted to SEK 44 (20) million. · Earnings per share for the period before and after dilution amounted to SEK 0.78 (0.67). “The Group has reported strong organic growth during the past quarters and this trend continued during the second quarter as well. Net sales increased with 86 % during the second quarter, of which 25 % was organic growth

Apetit’s comparable profitability was lower than last year – net sales grew, the sharp increase in costs posed challenges

Apetit Plc, Half-Year Report on 18 August 2022 at 08:30 a.m.Apetit Plc’s Half-Year Report 1 January–30 June 2022 Apetit’s comparable profitability was lower than last year – net sales grew, the sharp increase in costs posed challenges April–June 2022, continuing operations*) · In continuing operations, comparable net sales increased by 40 per cent to EUR 47.3 (33.8) million. EBITDA was EUR 0.4 (1.7) million. Operating profit was EUR -1.0 (0.4) million. The sharp increase in the prices of production inputs could not be fully transferred to sales prices. · The net sales of Food

Starbreeze AB (publ) Interim Report Q2 2022

Second quarter 2022 · Net sales totaled SEK 31.8 million (32.0). PAYDAY accounted for SEK 30.0 million (31.5). · EBITDA totaled SEK 18.1 million (-51.8). · Depreciation, amortization and impairment totaled SEK 14.8 million (15.5). · Profit/loss before tax was SEK -10.8 million (-80.0). · Basic and diluted earnings per share totaled SEK -0.02 (-0.11). · On June 21, Midland Ranch Heist was successfully released as part of the Texas Heat campaign. CEO Tobias Sjögren remarks on the report: WE CONTINUE ACCORDING TO OUR STRATEGY TO DEVELOP STARBREEZE The games market in

There are no items matching the current filter
There are no more items matching the current filter
Back to top